02617.HK
TransThera Sciences (Nanjing) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 10.15
+0.59%Margins
Gross margin
87.7%
EBITDA margin
-765.3%
EBIT margin
-1133.2%
Net margin
-767.3%
FCF margin
-413.4%
-30.6%
Return on equity
-27.2%
Return on assets
-44.8%
Return on invested capital
0.04x
Asset turnover
-HKD 168.4M
Cash from operations
HKD 2.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026